New prosthetic ankle is successfully implanted
The world renowned surgeon from Basel, Beat Hintermann, has successfully implanted ankle prosthesis of his own design in five patients in Liestal. Hintermann products are distributed by the U.S. company DT MedTech LLC.
Beat Hintermann is a world renowned foot and ankle surgeon. He is also a professor at the University of Basel and has developed a range of ankle prosthesis known as the Hintermann Series.
Since 2016, these prosthesis have been produced and distributed by the U.S. company DT MedTech LLC.
Now, DT MedTech has announced that Hintermann has successfully implanted his new two-component, semi-constrained total ankle prosthesis in five patients in Liestal.
Four of the procedures were total ankle replacements and the fifth was a takedown of a mal-position arthrodesis.
The new development is indicated for painful arthritic ankle joints due to primary osteoarthritis, post-traumatic osteoarthritis, or arthritis secondary to inflammatory disease.
The prosthesis can also be used as a revision for failed ankle replacements or non-union and mal-union of immobile ankle joints.
“I am extremely pleased with the outcomes of the recent H2 surgeries performed, especially as the patients were able to bear their own weight just 24 hours after the devices were implanted,” commented Hintermann in the statement.
Thanks to the new prosthesis, he can expand patient selection for total ankle replacements.
Share this article
You might also be interested in
Evolva launches new line for manufacturers of personal care products
Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...Read More
Record figure for startups in the Basel Area
Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...Read More
Noema Pharma raises 103 million Swiss francs from investors
Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....Read More
Why CDMO companies choose the Basel Area as their location
Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...Read More
Basel still the most attractive small city for business in Europe
As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...Read More
Ariceum Therapeutics establishes subsidiary in Basel
The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...Read More
RocketVax raises fresh capital
The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...Read More
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...Read More
KUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...Read More
Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...Read More